NYRADA INC (ASX:NYR) 60 Consolidated Entity Disclosure Statement Entity name Entity type Place formed/ Country of incorporation Ownership interest % Tax residency Nyrada Inc Body corporate United States of America N/A United States of America & Australia Nyrada Pty Limited Body corporate Australia 100.00% Australia Norbio No.2 Pty Limited Body corporate Australia 100.00% Australia Cardio Therapeutics Pty Limited Body corporate Australia 100.00% Australia Basis of preparation This Consolidated entity disclosure statement (CEDS) has been prepared in accordance with the Corporations Act 2001 and includes information for each entity that was part of the Consolidated Entity as at the end of the financial year in accordance with AASB 10 Consolidated Financial Statements. Determination of tax residency Section 295 (3A)(vi) of the Corporation Act 2001 defines tax residency as having the meaning in the Income Tax Assessment Act 1997. The determination of tax residency involves judgement as there are different interpretations that could be adopted, and which could give rise to a different conclusion on residency. In determining tax residency, the Group has applied the following interpretations: Australian tax residency The Group has applied current legislation and judicial precedent, including having regard to the Tax Commissioner's public guidance in Tax Ruling TR 2018/5. Foreign tax residency Where necessary, the Group has used independent tax advisers in foreign jurisdictions to assist in its determination of tax residency to ensure applicable foreign tax legislation has been complied with (see section 295(3A)(vii) of the Corporations Act 2001). Partnerships and Trusts None of the entities noted above were trustees of trusts within the Group, partners in a partnership within the Group or participants in a joint venture within the Group.
RkJQdWJsaXNoZXIy MjE2NDg3